ArticleFrontiers in public health2026
Benchmarking public large language model responses to patient-facing inflammatory bowel disease questions: informational quality, transparency proxies, and readability.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Patient-facing diabetic foot information from large language models: a domain- and source-balanced prompt framework for public-interface benchmarking.Frontiers in endocrinology · 2026Article
- Quality, readability, and clinical-risk signals of default public-interface LLM responses to vascular and perioperative patient questions: a cross-sectional snapshot.Frontiers in public health · 2026Article
- Benchmarking publicly accessible large language models for English-language patient-facing acute pancreatitis information: a cross-sectional study of quality, transparency, and readability.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patient-facing large language model (LLM) outputs for inflammatory bowel disease (IBD) must be decision-relevant, readable, and verifiable. Methods: In a cross-sectional benchmark using a guideline-derived question set, five publicly available LLMs provided answers to 20 single-intent patient IBD questions, mapped to prespecified decision-critical domains across the care pathway (100 model-question responses). Queries were conducted from January 17-24, 2026, Results: Interrater agreement was high [DISCERN ICC(A,1) = 0.842; EQIP ICC(A,1) = 0.760; GQS weighted κ = 0.812; JAMA weighted κ = 0.936]. Median DISCERN scores ranged from 43.5 to 57.5, and EQIP scores ranged from 67.5 to 77.5, while transparency remained limited (JAMA median 0-1/4). Readability consistently failed to meet patient targets, with grade-level indices exceeding sixth grade and Flesch Reading Ease medians ranging from 15 to 36 (compared to a target of ≥80 for "easy" readability). All 10 outcomes varied significantly across models (Holm-adjusted Conclusion: Under default settings, publicly available LLMs exhibit variable informational quality for IBD but consistently poor transparency and readability. Patient-facing deployment should mandate provenance, currency, and disclosure fields, as well as outputs targeted to appropriate grade levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.